Rapid identification of Coronaviruses including SARS-CoV-2 and detection of its mutations.

TECHNOLOGY SUMMARY

Rapid diagnostic assay for the in-field identification of Coronaviruses including SARS-CoV-2 and the detection of mutations in its spike protein from human nasal, buccal or saliva samples. It can be used and easily read by individuals without medical expertise to provide integrated sample-to-answer in less than 30 minutes.

AREA/MATURITY/AWARDS

Primary Application Area: Biotech, Pharma, Health

Technology Development Status: Prototype

Technology Readiness Level: TRL 3


SHOWCASE SUMMARY

Organization Type: Mid-stage Startup (A or B)


MARKET KEYWORDS

Market Keywords: muscle strength restoration, muscle health, post-injury care